HealthQuill WHO
The WHO, has included noma in its official list of neglected tropical diseases to expand health services to the world’s most vulnerable populations.
Drugs Health Pharma

Noma added to WHO’s list of 21 neglected tropical diseases 

HQ Team December 21, 2023: The WHO, has included noma in its official list of neglected tropical diseases to expand health services to.

Read More
Teenagers are using e-cigarettes at a rate higher than adults, and in England, the numbers have tripled in the past three years, according to the World Health Organization.
Drugs Health Pharma

Teenagers smoking e-cigarettes at a faster rate than adults: WHO

HQ Team December 15, 2023: Teenagers are using e-cigarettes at a rate higher than adults, and in England, the numbers have tripled in.

Read More
African researchers and European scientists, conducting clinical trials for an HIV vaccine, have halted further vaccinations after they turned out to be ineffective in preventing people from getting the virus.
Drugs Health Pharma

African-European HIV vaccine clinical trials come to a grinding halt

HQ Team December 11, 2023: African researchers and European scientists, conducting clinical trials for an HIV vaccine, have halted further vaccinations after they turned.

Read More
An “unprecedented” outbreak of anthrax, with 684 suspected human cases, has been reported from Zambia, according to the WHO.
Drugs Health Pharma

Zambia sees ‘unprecedented’ outbreak of anthrax: WHO 

HQ Team December 9, 2023: An “unprecedented” outbreak of anthrax, with 684 suspected human cases, has been reported from Zambia, according to the.

Read More
The current global risk from cholera is “very high” with vaccines running short of demand, the World Health Organization stated.
Drugs Health Pharma

WHO maintains global cholera risk at “very high” category

HQ Team December 8, 2023: The current global risk from cholera is “very high” with vaccines running short of demand, the World Health.

Read More
About 40 million women, or one-third, were likely to have a long-term childbirth-related health problem, which is often ignored in clinical research, practice and policy, a Lancet report quoted by the WHO stated.
Health Medical Pharma

40 million women susceptible to long-term childbirth health issues: Study

HQ Team December 7, 2023: About 40 million women, or one-third, were likely to have a long-term childbirth-related health problem, which is often.

Read More
Pneumonia is a form of acute respiratory infection that affects the lungs and kills more children than any other infectious disease. Every day at least one child dies from pneumonia every 43 seconds, according to UNICEF.
Drugs Health Pharma

Opinion: Steps for prevention, spread, and monitoring pneumonia

By K. Leelamoni November 5, 2023: Outbreaks of pneumonia affecting children in parts of northern China, the US,  the Netherlands, and Denmark are higher than.

Read More
A clutch of 41 multilateral development banks, funders, countries and philanthropies announced a global funding plan to cut greenhouse gas emissions and to protect people from climate risks to health.
Climate Health Pharma

COP28: Funding pathway to cut emissions, protect people from risks

HQ Team November 2, 2023: A clutch of 41 multilateral development banks, funders, countries and philanthropies announced a global funding plan to cut.

Read More
Mosquitoes by the evening. Image Credit: Wolfgang Hasselmann on Unsplash
Climate Drugs Pharma

WHO global malaria strategy ‘off track by a wide margin’

HQ Team November 30, 2023: The Covid-19 pandemic significantly disrupted malaria services, leading to a surge in both incidence and mortality rates, exacerbating.

Read More
The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global health agency reported an 8.9% rise in global prevalence in cases arising in the UK, France and Sweden.
Drugs Health Pharma

Omicron mutant BA.2.86 reclassified as ‘variant of interest’ by WHO 

HQ Team November 29, 2023: The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global.

Read More